A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
A Single-center, Open-label Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
Galderma R&D
25 participants
Oct 21, 2025
INTERVENTIONAL
Conditions
Summary
Adult subjects with moderate-to-severe cheek wrinkles will be treated with Sculptra for correction of fine lines and wrinkles in the cheek area.
Eligibility
Inclusion Criteria10
- Adult subjects aged 45-65 years old
- Females only
- Subject with moderate-to-severe cheek wrinkles on the GCWS
- Subject with intent to undergo correction of cheek wrinkles on both sides of the face
- Subject who in the opinion of the Investigator would need 3 treatments for optimal clinical outcomes
- Subject willing to be photographed at each visit.
- Subjects willing to stop using current facial skincare products for the duration of the study.
- Subject willing to replace the current facial skincare products with the provided facial skincare products, including cleanser, moisturizer and sunscreen, until study completion.
- Ability to read, understand and give consent for participation in the study.
- Agreement to adhere to the procedures and requirements of the study and to report to the site on the day(s) and at the time(s) scheduled for the assessments.
Exclusion Criteria4
- Subjects with a history of allergy or hypersensitivity to any ingredient of the treatment products.
- Previous tissue-augmenting therapy, contouring, or revitalization treatment in the face, except lips.
- Previous treatment/procedure in the face in the previous 6 months that, in the Investigator's opinion, would interfere with the study injections and/or study assessments or exposed the study subject to undue risk by study participation, or planning to undergo any of these procedures affecting the treatment area at any time during the study.
- Subjects with any medical condition that, in the opinion of the Investigator, would make the subject unsuitable for inclusion.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Sculptra injection will be performed to the cheeks using 25 G needle size. Injections will be performed subdermally, i.e., in the subcutaneous and supraperiosteal region. A maximum of 18 mL (2 vials) of Sculptra will be administered per treatment session with a maximum of 9 mL (1 vial) per cheek, evenly distributed within the treatment area.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07399028